Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
12 Jun, 2026, 11.55 AM IST
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
11 Jun, 2026, 10.31 AM IST
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
02 Jun, 2026, 03.30 PM IST
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
24 May, 2026, 04.23 PM IST
Dividends, bonus issues: TCS, LIC, Bajaj Auto among 30 stocks turning ex-date this week. Check detailsInvestors must hold shares of these companies in their demat accounts on the record date to be eligible for the respective corporate action...
24 May, 2026, 12.23 PM IST
Bond yields, FIIs and corporate actions among 8 factors to steer D-Street this weekNifty closed marginally higher last week, driven by IT and energy stocks, as markets brace for key events. Technical analysts suggest Nifty...
24 May, 2026, 10.23 AM IST
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
20 May, 2026, 08.06 PM IST
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
19 May, 2026, 10.34 AM IST
Capitalmind Flexi Cap Fund exits RIL and 2 others, hikes stake in Titan Company, MCX and 16 other stocks in AprilCapitalmind Flexi Cap Fund exited Reliance Industries, Bank of Baroda, and L&T Finance in April. The fund also increased stakes in Titan Co...
15 May, 2026, 11.43 AM IST
Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
14 May, 2026, 06.26 AM IST
Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
14 May, 2026, 12.43 AM IST
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
04 May, 2026, 06.00 AM IST
Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...
28 Apr, 2026, 01.17 AM IST
ET Family Business Awards: Torrent Pharma drives growth through acquisitions and innovationAman Mehta is guiding Torrent Pharmaceuticals through a significant period of growth and strategic change. He is driving the company's expa...
23 Apr, 2026, 09.05 PM IST
Buy Torrent Pharmaceuticals, target price Rs 2250: Prabhudas LilladherTorrent Pharmaceuticals Ltd., incorporated in the year 1972, is a Large Cap company (having a market cap of Rs 63896.81 Crore) operating in...
25 Oct, 2023, 10.24 AM IST
- Buy Torrent Pharmaceuticals Ltd with a target of Rs 1150: Prakash Gaba
"Torrent Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 1150 and a stop loss of Rs 1060."
15 Dec, 2014, 01.17 PM IST
- Buy Torrent Pharmaceuticals Ltd with a target of Rs 1160: Ashwani Gujral
"Torrent Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 1160 and a stop loss of Rs 1090."
02 Dec, 2014, 09.04 AM IST